Dr. Urnovitz has 35 years in biotechnology and medical devices. He was the CEO-Founder of 2 previous companies whose clinically useful products were designed, funded, tested by him. One product received 2 FDA approvals for a urine test for HIV. A second product is a lab developed test for monitoring metastatic cancers during immunotherapy.

Julien brings 8 years' experience in B2B business development. Prior to co-founding FBB Biomed, Julien was a business development executive at AI-enabled process automation firm Genpact, where he closed multi-million dollar contracts and developed partnerships with tech companies.

Garry Neil MD has held a number of senior positions in the pharmaceutical industry, academia and venture capital (Apple Tree Partners). These include Corporate VP of Science & Technology at Johnson & Johnson, and Group President at Johnson & Johnson Pharmaceutical Research and Development, VP of R&D at Merck KGaA/EMD Pharmaceuticals, VP of Clinical Research at Astra Zeneca and Astra Merck. Dr. Neil serves on the Board of Reagan Udall Foundation.

Built FDA approved laboratories. 30 years of experience in regulated laboratories.